Literature DB >> 14988250

Parasympathetic blockade attenuates augmented pancreatic polypeptide but not insulin secretion in Pima Indians.

Barbora Vozarova de Courten1, Christian Weyer, Norbert Stefan, Mark Horton, Angelo DelParigi, Peter Havel, Clifton Bogardus, P Antonio Tataranni.   

Abstract

There is evidence from animal models of obesity and type 2 diabetes that increased parasympathetic vagal input to the pancreas contributes to hyperinsulinemia. Compared with Caucasians, Pima Indians have a high risk of type 2 diabetes and exhibit marked hyperinsulinemia and elevated plasma levels of pancreatic polypeptide (PP), an islet hormone considered a surrogate marker of parasympathetic nervous system (PNS) drive to the pancreas. To test if hyperinsulinemia in Pima Indians is due to increased vagal input to the beta-cell, we examined the effect of PNS blockade in 17 Caucasian (aged 35 +/- 8 years, body fat 23 +/- 7% [mean +/- SD]) and 17 Pima Indian males (aged 28 +/- 8 years, body fat 29 +/- 5%) with normal glucose tolerance. Each participant underwent four consecutive standardized liquid meal tests (64% carbohydrate, 22% fat, and 14% protein) during which a primed infusion of atropine was administered for 120 min at the following doses: 0, 2.5, 5, and 10 micro g. kg fat-free mass (FFM)(-1). h(-1). Areas under the curve for early (AUC(0-30 min)) and total (AUC(0-120 min)) postprandial insulin and PP secretory responses were calculated. Early postprandial insulin and PP secretory responses were higher in Pima Indians compared with those of Caucasians (both P = 0.01). Secretion of insulin and PP was inhibited by atropine (both P < 0.001). Increasing doses of atropine attenuated the ethnic difference in PP (P = 0.01) but not in early insulin secretory responses (P = 0.6), an effect that was not due to differences in gastric emptying rate (acetaminophen test) and/or circulating glucose. Similar results were observed for total secretory responses. These results confirm that compared with Caucasians, Pima Indians have an exaggerated PNS drive to pancreatic F-cells that secrete PP. However, the hyperinsulinemia of this population does not appear to be due to increased vagal input to pancreatic beta-cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14988250     DOI: 10.2337/diabetes.53.3.663

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  13 in total

1.  Plasma pancreatic polypeptide levels are associated with differences in body fat distribution in human subjects.

Authors:  J Tong; K M Utzschneider; D B Carr; S Zraika; J Udayasankar; F Gerchman; R H Knopp; S E Kahn
Journal:  Diabetologia       Date:  2006-12-15       Impact factor: 10.122

2.  Pancreatic polypeptide meal response may predict gastric band-induced weight loss.

Authors:  Andrew F R Dixon; Carel W le Roux; Mohammad A Ghatei; Stephen R Bloom; Toni L McGee; John B Dixon
Journal:  Obes Surg       Date:  2011-12       Impact factor: 4.129

Review 3.  Elevated pancreatic polypeptide levels in pancreatic neuroendocrine tumors and diabetes mellitus: causation or association?

Authors:  Jessica E Maxwell; Thomas M O'Dorisio; Andrew M Bellizzi; James R Howe
Journal:  Pancreas       Date:  2014-05       Impact factor: 3.327

4.  Fasting and meal-induced CCK and PP secretion following intragastric balloon treatment for obesity.

Authors:  Elisabeth M H Mathus-Vliegen; Gerrit H de Groot
Journal:  Obes Surg       Date:  2013-05       Impact factor: 4.129

5.  Evidence that autonomic mechanisms contribute to the adaptive increase in insulin secretion during dexamethasone-induced insulin resistance in humans.

Authors:  B Ahrén
Journal:  Diabetologia       Date:  2008-04-24       Impact factor: 10.122

6.  Gastric bypass alters both glucose-dependent and glucose-independent regulation of islet hormone secretion.

Authors:  Marzieh Salehi; Stephen C Woods; David A D'Alessio
Journal:  Obesity (Silver Spring)       Date:  2015-08-28       Impact factor: 5.002

7.  Acetylcholinesterase (AChE) inhibition aggravates fasting-induced triglyceride accumulation in the mouse liver.

Authors:  Shin-Ichi Yokota; Kaai Nakamura; Midori Ando; Hiroyasu Kamei; Fumihiko Hakuno; Shin-Ichiro Takahashi; Shigenobu Shibata
Journal:  FEBS Open Bio       Date:  2014-10-22       Impact factor: 2.693

8.  Early postnatal low-protein nutrition, metabolic programming and the autonomic nervous system in adult life.

Authors:  Júlio Cezar de Oliveira; Sabrina Grassiolli; Clarice Gravena; Paulo Cezar Freitas de Mathias
Journal:  Nutr Metab (Lond)       Date:  2012-09-11       Impact factor: 4.169

9.  Early changes in ghrelin following Roux-en-Y gastric bypass: influence of vagal nerve functionality?

Authors:  Magnus Sundbom; Camilla Holdstock; Britt Eden Engström; F Anders Karlsson
Journal:  Obes Surg       Date:  2007-03       Impact factor: 3.479

10.  Cholinergic regulation of ghrelin and peptide YY release may be impaired in obesity.

Authors:  Christina Maier; Michaela Riedl; Greisa Vila; Peter Nowotny; Michael Wolzt; Martin Clodi; Bernhard Ludvik; Anton Luger
Journal:  Diabetes       Date:  2008-06-20       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.